Investigator Initiated Study to Assess the Efficacy of OC-01 (Varenicline) Nasal Spray on Signs and Symptoms of Dry Eye Disease Following Laser-assisted in Situ Keratomileusis (LASIK)
Condition: Dry Eye Disease Interventions: Drug: OC-01 (varenicline 0.6mg/ml) nasal spray; Drug: Placebo (vehicle) nasal spray Sponsor: Vance Thompson Vision ND Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - October 19, 2021 Category: Research Source Type: clinical trials
Comparison of Outcomes Between TransPRK and Off-flap Epi-LASIK
Condition: Refractive Surgery Intervention: Sponsor: Wenzhou Medical University Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 28, 2021 Category: Research Source Type: clinical trials